Table of Contents Chapter 1 Overview of Precision Medicine 1.1 Definition of Precision Medicine in This Report 1.2 Commercial Types of Precision Medicine 1.2.1 Drug discovery 1.2.2 Companion diagnostics 1.2.3 Sequencing 1.2.4 Bio-informatics 1.2.5 Others 1.3 Downstream Application of Precision Medicine 1.3.1 Oncology 1.3.2 CNS 1.3.3 Immunology 1.3.4 Respiratory 1.3.5 Others 1.4 Development History of Precision Medicine 1.5 Market Status and Trend of Precision Medicine 2013-2023 1.5.1 Global Precision Medicine Market Status and Trend 2013-2023 1.5.2 Regional Precision Medicine Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Precision Medicine 2013-2017 2.2 Sales Market of Precision Medicine by Regions 2.2.1 Sales Volume of Precision Medicine by Regions 2.2.2 Sales Value of Precision Medicine by Regions 2.3 Production Market of Precision Medicine by Regions 2.4 Global Market Forecast of Precision Medicine 2018-2023 2.4.1 Global Market Forecast of Precision Medicine 2018-2023 2.4.2 Market Forecast of Precision Medicine by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Precision Medicine by Types 3.2 Sales Value of Precision Medicine by Types 3.3 Market Forecast of Precision Medicine by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Precision Medicine by Downstream Industry 4.2 Global Market Forecast of Precision Medicine by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Precision Medicine Market Status by Countries 5.1.1 North America Precision Medicine Sales by Countries (2013-2017) 5.1.2 North America Precision Medicine Revenue by Countries (2013-2017) 5.1.3 United States Precision Medicine Market Status (2013-2017) 5.1.4 Canada Precision Medicine Market Status (2013-2017) 5.1.5 Mexico Precision Medicine Market Status (2013-2017) 5.2 North America Precision Medicine Market Status by Manufacturers 5.3 North America Precision Medicine Market Status by Type (2013-2017) 5.3.1 North America Precision Medicine Sales by Type (2013-2017) 5.3.2 North America Precision Medicine Revenue by Type (2013-2017) 5.4 North America Precision Medicine Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Precision Medicine Market Status by Countries 6.1.1 Europe Precision Medicine Sales by Countries (2013-2017) 6.1.2 Europe Precision Medicine Revenue by Countries (2013-2017) 6.1.3 Germany Precision Medicine Market Status (2013-2017) 6.1.4 UK Precision Medicine Market Status (2013-2017) 6.1.5 France Precision Medicine Market Status (2013-2017) 6.1.6 Italy Precision Medicine Market Status (2013-2017) 6.1.7 Russia Precision Medicine Market Status (2013-2017) 6.1.8 Spain Precision Medicine Market Status (2013-2017) 6.1.9 Benelux Precision Medicine Market Status (2013-2017) 6.2 Europe Precision Medicine Market Status by Manufacturers 6.3 Europe Precision Medicine Market Status by Type (2013-2017) 6.3.1 Europe Precision Medicine Sales by Type (2013-2017) 6.3.2 Europe Precision Medicine Revenue by Type (2013-2017) 6.4 Europe Precision Medicine Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Precision Medicine Market Status by Countries 7.1.1 Asia Pacific Precision Medicine Sales by Countries (2013-2017) 7.1.2 Asia Pacific Precision Medicine Revenue by Countries (2013-2017) 7.1.3 China Precision Medicine Market Status (2013-2017) 7.1.4 Japan Precision Medicine Market Status (2013-2017) 7.1.5 India Precision Medicine Market Status (2013-2017) 7.1.6 Southeast Asia Precision Medicine Market Status (2013-2017) 7.1.7 Australia Precision Medicine Market Status (2013-2017) 7.2 Asia Pacific Precision Medicine Market Status by Manufacturers 7.3 Asia Pacific Precision Medicine Market Status by Type (2013-2017) 7.3.1 Asia Pacific Precision Medicine Sales by Type (2013-2017) 7.3.2 Asia Pacific Precision Medicine Revenue by Type (2013-2017) 7.4 Asia Pacific Precision Medicine Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Precision Medicine Market Status by Countries 8.1.1 Latin America Precision Medicine Sales by Countries (2013-2017) 8.1.2 Latin America Precision Medicine Revenue by Countries (2013-2017) 8.1.3 Brazil Precision Medicine Market Status (2013-2017) 8.1.4 Argentina Precision Medicine Market Status (2013-2017) 8.1.5 Colombia Precision Medicine Market Status (2013-2017) 8.2 Latin America Precision Medicine Market Status by Manufacturers 8.3 Latin America Precision Medicine Market Status by Type (2013-2017) 8.3.1 Latin America Precision Medicine Sales by Type (2013-2017) 8.3.2 Latin America Precision Medicine Revenue by Type (2013-2017) 8.4 Latin America Precision Medicine Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Precision Medicine Market Status by Countries 9.1.1 Middle East and Africa Precision Medicine Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Precision Medicine Revenue by Countries (2013-2017) 9.1.3 Middle East Precision Medicine Market Status (2013-2017) 9.1.4 Africa Precision Medicine Market Status (2013-2017) 9.2 Middle East and Africa Precision Medicine Market Status by Manufacturers 9.3 Middle East and Africa Precision Medicine Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Precision Medicine Sales by Type (2013-2017) 9.3.2 Middle East and Africa Precision Medicine Revenue by Type (2013-2017) 9.4 Middle East and Africa Precision Medicine Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Precision Medicine 10.1 Global Economy Situation and Trend Overview 10.2 Precision Medicine Downstream Industry Situation and Trend Overview Chapter 11 Precision Medicine Market Competition Status by Major Manufacturers 11.1 Production Volume of Precision Medicine by Major Manufacturers 11.2 Production Value of Precision Medicine by Major Manufacturers 11.3 Basic Information of Precision Medicine by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Precision Medicine Major Manufacturer 11.3.2 Employees and Revenue Level of Precision Medicine Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Precision Medicine Major Manufacturers Introduction and Market Data 12.1 AB-Biotics Sa 12.1.1 Company profile 12.1.2 Representative Precision Medicine Product 12.1.3 Precision Medicine Sales, Revenue, Price and Gross Margin of AB-Biotics Sa 12.2 Abbott Laboratories 12.2.1 Company profile 12.2.2 Representative Precision Medicine Product 12.2.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Abbott Laboratories 12.3 Almac Group 12.3.1 Company profile 12.3.2 Representative Precision Medicine Product 12.3.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Almac Group 12.4 Asuragen 12.4.1 Company profile 12.4.2 Representative Precision Medicine Product 12.4.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Asuragen 12.5 Biobase Gmbh (Subsidiary) 12.5.1 Company profile 12.5.2 Representative Precision Medicine Product 12.5.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Biobase Gmbh (Subsidiary) 12.6 Biomérieux Sa 12.6.1 Company profile 12.6.2 Representative Precision Medicine Product 12.6.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Biomérieux Sa 12.7 Caris Life Sciences 12.7.1 Company profile 12.7.2 Representative Precision Medicine Product 12.7.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Caris Life Sciences 12.8 Cepheid Inc. 12.8.1 Company profile 12.8.2 Representative Precision Medicine Product 12.8.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Cepheid Inc. 12.9 Cetics Healthcare Technologies Gmbh 12.9.1 Company profile 12.9.2 Representative Precision Medicine Product 12.9.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Cetics Healthcare Technologies Gmbh 12.10 GE Healthcare 12.10.1 Company profile 12.10.2 Representative Precision Medicine Product 12.10.3 Precision Medicine Sales, Revenue, Price and Gross Margin of GE Healthcare 12.11 Glaxosmithkline (Gsk) 12.11.1 Company profile 12.11.2 Representative Precision Medicine Product 12.11.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Glaxosmithkline (Gsk) 12.12 Healthcore 12.12.1 Company profile 12.12.2 Representative Precision Medicine Product 12.12.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Healthcore 12.13 IBM 12.13.1 Company profile 12.13.2 Representative Precision Medicine Product 12.13.3 Precision Medicine Sales, Revenue, Price and Gross Margin of IBM 12.14 Intel Corporation 12.14.1 Company profile 12.14.2 Representative Precision Medicine Product 12.14.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Intel Corporation 12.15 Intomics A/S 12.15.1 Company profile 12.15.2 Representative Precision Medicine Product 12.15.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Intomics A/S 12.16 Johnson & Johnson 12.17 Laboratory Corporation Of America Holdings 12.18 Medtronic 12.19 Novartis 12.20 Qiagen 12.21 Quest Diagnostics 12.22 Randox Laboratories 12.23 Roche Holding Ag-Br 12.24 Takeda Pharmaceutical Company 12.25 Teva Pharmaceutical Industries Chapter 13 Upstream and Downstream Market Analysis of Precision Medicine 13.1 Industry Chain of Precision Medicine 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Precision Medicine 14.1 Cost Structure Analysis of Precision Medicine 14.2 Raw Materials Cost Analysis of Precision Medicine 14.3 Labor Cost Analysis of Precision Medicine 14.4 Manufacturing Expenses Analysis of Precision Medicine Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Drug discovery Table Advantage and Disadvantage of Companion diagnostics Table Advantage and Disadvantage of Sequencing Table Advantage and Disadvantage of Bio-informatics Table Advantage and Disadvantage of Others Table Sales Volume of Precision Medicine by Regions 2013-2017 Table Sales Value of Precision Medicine by Regions 2013-2017 Table Production Volume of Precision Medicine by Regions 2013-2017 Table Global Sales Volume of Precision Medicine by Regions 2018-2023 Table Global Sales Value of Precision Medicine by Regions 2018-2023 Table Global Production Volume of Precision Medicine by Regions 2018-2023 Table Sales Volume of Precision Medicine by Types 2013-2017 Table Sales Value of Precision Medicine by Types 2013-2017 Table Sales Volume Forecast of Precision Medicine by Types 2018-2023 Table Sales Value Forecast of Precision Medicine by Types 2018-2023 Table Sales Volume of Precision Medicine by Downstream Industry 2013-2017 Table Sales Volume Forecast of Precision Medicine by Downstream Industry 2018-2023 Table North America Precision Medicine Sales by Countries (2013-2017) Table North America Precision Medicine Sales Share by Countries (2013-2017) Table North America Precision Medicine Revenue by Countries (2013-2017) Table North America Precision Medicine Revenue Market Share by Countries (2013-2017) Table North America Precision Medicine Sales by Type (2013-2017) Table North America Precision Medicine Sales Share by Type (2013-2017) Table North America Precision Medicine Revenue by Type (2013-2017) Table North America Precision Medicine Revenue Share by Type (2013-2017) Table North America Precision Medicine Sales by Downstream Industry (2013-2017) Table North America Precision Medicine Sales Share by Downstream Industry (2013-2017) Table Europe Precision Medicine Sales by Countries (2013-2017) Table Europe Precision Medicine Sales Share by Countries (2013-2017) Table Europe Precision Medicine Revenue by Countries (2013-2017) Table Europe Precision Medicine Revenue Market Share by Countries (2013-2017) Table Europe Precision Medicine Sales by Type (2013-2017) Table Europe Precision Medicine Sales Share by Type (2013-2017) Table Europe Precision Medicine Revenue by Type (2013-2017) Table Europe Precision Medicine Revenue Share by Type (2013-2017) Table Europe Precision Medicine Sales by Downstream Industry (2013-2017) Table Europe Precision Medicine Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Precision Medicine Sales by Countries (2013-2017) Table Asia Pacific Precision Medicine Sales Share by Countries (2013-2017) Table Asia Pacific Precision Medicine Revenue by Countries (2013-2017) Table Asia Pacific Precision Medicine Revenue Market Share by Countries (2013-2017) Table Asia Pacific Precision Medicine Sales by Type (2013-2017) Table Asia Pacific Precision Medicine Sales Share by Type (2013-2017) Table Asia Pacific Precision Medicine Revenue by Type (2013-2017) Table Asia Pacific Precision Medicine Revenue Share by Type (2013-2017) Table Asia Pacific Precision Medicine Sales by Downstream Industry (2013-2017) Table Asia Pacific Precision Medicine Sales Share by Downstream Industry (2013-2017) Table Latin America Precision Medicine Sales by Countries (2013-2017) Table Latin America Precision Medicine Sales Share by Countries (2013-2017) Table Latin America Precision Medicine Revenue by Countries (2013-2017) Table Latin America Precision Medicine Revenue Market Share by Countries (2013-2017) Table Latin America Precision Medicine Sales by Type (2013-2017) Table Latin America Precision Medicine Sales Share by Type (2013-2017) Table Latin America Precision Medicine Revenue by Type (2013-2017) Table Latin America Precision Medicine Revenue Share by Type (2013-2017) Table Latin America Precision Medicine Sales by Downstream Industry (2013-2017) Table Latin America Precision Medicine Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Precision Medicine Sales by Regions (2013-2017) Table Middle East and Africa Precision Medicine Sales Share by Regions (2013-2017) Table Middle East and Africa Precision Medicine Revenue by Regions (2013-2017) Table Middle East and Africa Precision Medicine Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Precision Medicine Sales by Type (2013-2017) Table Middle East and Africa Precision Medicine Sales Share by Type (2013-2017) Table Middle East and Africa Precision Medicine Revenue by Type (2013-2017) Table Middle East and Africa Precision Medicine Revenue Share by Type (2013-2017) Table Middle East and Africa Precision Medicine Sales by Downstream Industry (2013-2017) Table Middle East and Africa Precision Medicine Sales Share by Downstream Industry (2013-2017) Table Production Volume of Precision Medicine by Major Manufacturers 2013-2017 Table Production Value of Precision Medicine by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Precision Medicine Major Manufacturer Table Employees and Revenue Level of Precision Medicine Major Manufacturer Table Representative Precision Medicine Product One of AB-Biotics Sa Table Representative Precision Medicine Product Two of AB-Biotics Sa Table Precision Medicine Sales, Revenue, Price and Gross Margin of AB-Biotics Sa 2013-2017 Table Representative Precision Medicine Product One of Abbott Laboratories Table Representative Precision Medicine Product Two of Abbott Laboratories Table Precision Medicine Sales, Revenue, Price and Gross Margin of Abbott Laboratories 2013-2017 Table Representative Precision Medicine Product One of Almac Group Table Representative Precision Medicine Product Two of Almac Group Table Precision Medicine Sales, Revenue, Price and Gross Margin of Almac Group 2013-2017 Table Representative Precision Medicine Product One of Asuragen Table Representative Precision Medicine Product Two of Asuragen Table Precision Medicine Sales, Revenue, Price and Gross Margin of Asuragen 2013-2017 Table Representative Precision Medicine Product One of Biobase Gmbh (Subsidiary) Table Representative Precision Medicine Product Two of Biobase Gmbh (Subsidiary) Table Precision Medicine Sales, Revenue, Price and Gross Margin of Biobase Gmbh (Subsidiary) 2013-2017 Table Representative Precision Medicine Product One of Biomérieux Sa Table Representative Precision Medicine Product Two of Biomérieux Sa Table Precision Medicine Sales, Revenue, Price and Gross Margin of Biomérieux Sa 2013-2017 Table Representative Precision Medicine Product One of Caris Life Sciences Table Representative Precision Medicine Product Two of Caris Life Sciences Table Precision Medicine Sales, Revenue, Price and Gross Margin of Caris Life Sciences 2013-2017 Table Representative Precision Medicine Product One of Cepheid Inc. Table Representative Precision Medicine Product Two of Cepheid Inc. Table Precision Medicine Sales, Revenue, Price and Gross Margin of Cepheid Inc. 2013-2017 Table Representative Precision Medicine Product One of Cetics Healthcare Technologies Gmbh Table Representative Precision Medicine Product Two of Cetics Healthcare Technologies Gmbh Table Precision Medicine Sales, Revenue, Price and Gross Margin of Cetics Healthcare Technologies Gmbh 2013-2017 Table Representative Precision Medicine Product One of GE Healthcare Table Representative Precision Medicine Product Two of GE Healthcare Table Precision Medicine Sales, Revenue, Price and Gross Margin of GE Healthcare 2013-2017 Table Representative Precision Medicine Product One of Glaxosmithkline (Gsk) Table Representative Precision Medicine Product Two of Glaxosmithkline (Gsk) Table Precision Medicine Sales, Revenue, Price and Gross Margin of Glaxosmithkline (Gsk) 2013-2017 Table Representative Precision Medicine Product One of Healthcore Table Representative Precision Medicine Product Two of Healthcore Table Precision Medicine Sales, Revenue, Price and Gross Margin of Healthcore 2013-2017 Table Representative Precision Medicine Product One of IBM Table Representative Precision Medicine Product Two of IBM Table Precision Medicine Sales, Revenue, Price and Gross Margin of IBM 2013-2017 Table Representative Precision Medicine Product One of Intel Corporation Table Representative Precision Medicine Product Two of Intel Corporation Table Precision Medicine Sales, Revenue, Price and Gross Margin of Intel Corporation 2013-2017 Table Representative Precision Medicine Product One of Intomics A/S Table Representative Precision Medicine Product Two of Intomics A/S Table Precision Medicine Sales, Revenue, Price and Gross Margin of Intomics A/S 2013-2017